Clinical points and experience in nucleic acid testing of SARS-CoV-2
10.3969/j.issn.1673-4130.2020.05.003
- VernacularTitle:新型冠状病毒核酸临床检测要点及经验
- Author:
Huiyu ZHONG
1
Author Information
1. 四川大学华西医院实验医学科,四川成都,610041
- Keywords:
severe acute respiratory syndrome coronavirus 2;
COVID-2019;
nucleic acid detection;
diagnosis
- From:
International Journal of Laboratory Medicine
2020;41(5):523-526
- CountryChina
- Language:Chinese
-
Abstract:
The number of pneumonia cases caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections has risen rapidly since December 2019. Because the presence of viral nucleic acid in patients is the only basis for the diagnosis，and the positive rate of nucleic acid detection is generally not satisfactory in clinical practice，so there are high requirements for the laboratory conditions，inspectors of viral nucleic acid detection and other aspects of the detection process. This paper focuses on the current situation, the latest industry standards and the consensus contents of the SARS-CoV-2 nucleic acid testing, and probes into the difficult problems in clinical testing, so as to provide theoretical basis for the accurate diagnosis of the COVID-2019.
